← Leaderboards

Elizabeth Schmidt Didier

Tulane University Of Louisiana

Google Scholar ↗PubMed ↗ORCID ↗

$8,050,961

Attributed

$9,500,144

Total exposure

54

Grants

35

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY2005–20

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

Funding mix

By agency

NIH$9,500,144 · 54

By mechanism

R01$3,753,134 · 2

P51$2,648,358 · 48

U42$1,856,156 · 2

R56$844,589 · 1

N01$397,907 · 1

Top collaborators

Marcelo J Kuroda4 shared

Most similar at Tulane University Of Louisiana

Same institution · by research overlap

Louis N. Martin$599,825
Linda B Green$108,654

Others in their field

Top investigators on “Grant”

David R. Weir · University Of Michigan At Ann Arbor$373,949,788
David Heimbrook · Leidos Biomedical Research, Inc.$341,196,902
Eric S Lander · Whitehead Institute For Biomedical Res$323,181,457
Jeffrey P Krischer · University Of South Florida$258,583,867
Lawrence Corey · Fred Hutchinson Cancer Center$253,286,867
Barton F Haynes · Duke University$243,251,908

Research focus

GrantResearch PersonnelSourceUnited States National Institutes Of HealthFundingResourcesNonhuman PrimateComputer Retrieval Of Information On Scientific Projects DatabaseInfectionInstitutionMicrosporidia (Protozoa)VirusMacaca MulattaAnimalsPrimatesInflammationDiagnosisImmuneReportingReproduction SporesBaseAidsMacrophageAnimal Colony

Grant awards (73)

Targeting Macrophages in Aging SIV-Infected Rhesus Macaques$679,151

R01 · FY2020 · HL

Viral Testing Core$349,994

U42 · FY2020 · OD · contact PI

Targeting Macrophages in Aging SIV-Infected Rhesus Macaques$687,696

R01 · FY2019 · HL

Viral Testing Core$349,994

U42 · FY2019 · OD · contact PI

Targeting Macrophages in Aging SIV-Infected Rhesus Macaques$702,577

R01 · FY2018 · HL

Viral Testing Core$349,994

U42 · FY2018 · OD · contact PI

Viral Testing Core - Maintenance of an SPF Macaque Breeding Colony for AIDS Research$228,076

U42 · FY2018 · OD · contact PI

Targeting Macrophages in Aging SIV-Infected Rhesus Macaques$828,942

R01 · FY2017 · HL · contact PI

Viral Testing Core$349,994

U42 · FY2017 · OD · contact PI

Viral Testing Core - Maintenance of an SPF Macaque Breeding Colony for AIDS Research$228,104

U42 · FY2017 · OD · contact PI

Rhesus Macaque Model of Accelerated Aging$844,589

R56 · FY2016 · AG · contact PI

PATHOGEN DETECTION AND QUANTIFICATION CORE$57,750

P51 · FY2011 · RR · contact PI

GASTROINTESTINAL DISEASE IN CAPTIVE RHESUS MACAQUES$37,186

P51 · FY2011 · RR · contact PI

NONHUMAN PRIMATE MODEL OF IMMUNOSENESCENCE AND VACCINATION$37,186

P51 · FY2011 · RR · contact PI

IMMUNE RESPONSES TO MICROSPORIDIA$37,186

P51 · FY2011 · RR · contact PI

PATHOGEN DETECTION AND QUANTIFICATION CORE$61,801

P51 · FY2010 · RR · contact PI

GASTROINTESTINAL DISEASE IN CAPTIVE RHESUS MACAQUES$61,801

P51 · FY2010 · RR · contact PI

NONHUMAN PRIMATE MODEL OF IMMUNOSENESCENCE AND VACCINATION$61,801

P51 · FY2010 · RR · contact PI

DIAGNOSTICS FOR MICROSPORIDIA$61,801

P51 · FY2010 · RR · contact PI

IMMUNE RESPONSES TO MICROSPORIDIA$61,801

P51 · FY2010 · RR · contact PI

IMMUNE RESPONSES TO MICROSPORIDIA$60,549

P51 · FY2009 · RR · contact PI

GENE TARGETS OF ANTIMICROSPORIDIAL DRUGS$60,549

P51 · FY2009 · RR · contact PI

NONHUMAN PRIMATE MODEL OF IMMUNOSENESCENCE AND VACCINATION$57,967

P51 · FY2009 · RR · contact PI

DIAGNOSTICS FOR MICROSPORIDIA$57,967

P51 · FY2009 · RR · contact PI

GASTROINTESTINAL DISEASE IN CAPTIVE RHESUS MACAQUES$57,967

P51 · FY2009 · RR · contact PI

ENTEROCYTOZOON BIENEUSI MONKEY MODEL$64,630

P51 · FY2008 · RR · contact PI

CASE REPORTS OF MICROSPORIDIOSIS$24,103

P51 · FY2008 · RR · contact PI

ENVIRONMENTAL STUDIES ON MICROSPORIDIA$24,103

P51 · FY2008 · RR · contact PI

IMMUNE RESPONSES TO MICROSPORIDIA$24,103

P51 · FY2008 · RR · contact PI

GENE TARGETS OF ANTIMICROSPORIDIAL DRUGS$24,103

P51 · FY2008 · RR · contact PI

GENE TARGETS OF ANTIMICROSPORIDIAL DRUGS$71,638

P51 · FY2007 · RR · contact PI

ANTIMICROSPORIDIAL DRUG DISCOVERY$71,638

P51 · FY2007 · RR · contact PI

ENTEROCYTOZOON BIENEUSI MONKEY MODEL$71,638

P51 · FY2007 · RR · contact PI

CASE REPORTS OF MICROSPORIDIOSIS$30,391

P51 · FY2007 · RR · contact PI

ENVIRONMENTAL STUDIES ON MICROSPORIDIA$30,391

P51 · FY2007 · RR · contact PI

IMMUNE RESPONSES TO MICROSPORIDIA$30,391

P51 · FY2007 · RR · contact PI

ANTIMICROSPORIDIAL DRUG DISCOVERY$65,435

P51 · FY2006 · RR · contact PI

ENTEROCYTOZOON BIENEUSI MONKEY MODEL$65,435

P51 · FY2006 · RR · contact PI

IMMUNE RESPONSES TO MICROSPORIDIA$65,435

P51 · FY2006 · RR · contact PI

ENVIRONMENTAL STUDIES ON MICROSPORIDIA$65,435

P51 · FY2006 · RR · contact PI

CASE REPORTS OF MICROSPORIDIOSIS$30,971

P51 · FY2006 · RR · contact PI

GENE TARGETS OF ANTIMICROSPORIDIAL DRUGS$30,971

P51 · FY2006 · RR · contact PI

ENVIRONMENTAL STUDIES ON MICROSPORIDIA$62,854

P51 · FY2005 · RR

IMMUNE RESPONSES TO MICROSPORIDIA$62,854

P51 · FY2005 · RR

ENTEROCYTOZOON BIENEUSI MONKEY MODEL$62,854

P51 · FY2005 · RR

ANTIMICROSPORIDIAL DRUG DISCOVERY$62,854

P51 · FY2005 · RR

GENE TARGETS OF ANTIMICROSPORIDIAL DRUGS$37,662

P51 · FY2005 · RR

Microporidiosis in AIDS$335,907

R01 · FY2004 · AI

ANTIMICROSPORIDIAL DRUG DISCOVERY$47,161

P51 · FY2004 · RR

ENVIRONMENTAL STUDIES ON MICROSPORIDIA$47,161

P51 · FY2004 · RR

IMMUNE RESPONSES TO MICROSPORIDIA$47,161

P51 · FY2004 · RR

ENTEROCYTOZOON BIENEUSI MONKEY MODEL$47,161

P51 · FY2004 · RR

MICROSPORIDIOSIS IN AN EGYPTIAN FRUIT BAT$46,011

P51 · FY2004 · RR

GENE TARGETS OF ANTIMICROSPORIDIAL DRUGS$46,011

P51 · FY2004 · RR

Microporidiosis in AIDS$335,907

R01 · FY2003 · AI

IMMUNE RESPONSES TO MICROSPORIDIA$61,560

P51 · FY2003 · RR

ANTIMICROSPORIDIAL DRUG DISCOVERY$61,560

P51 · FY2003 · RR

ENTEROCYTOZOON BIENEUSI MONKEY MODEL$61,560

P51 · FY2003 · RR

IMMUNOMAGNETIC BEAD SEPARATION (IMBS) ASSAY FOR CAPTURE OF MICROSPORIDIA$61,560

P51 · FY2003 · RR

IDENTIFICATION OF A NEW ENCEPHALITOZOON CUNICULI GENOTYPE$53,199

P51 · FY2003 · RR

GENE SURVEY SEQUENCE STUDY OF VITTAFORMA CORNEAE$53,199

P51 · FY2003 · RR

GENE TARGETS OF ANTIMICROSPORIDIAL DRUGS$53,199

P51 · FY2003 · RR

Microporidiosis in AIDS$182,954

R01 · FY2002 · AI

IN VITRO SCREEN OF COMPOUNDS FOR ANTIMICROSPORIDIAL ACTIVI:OPPORTUNISTIC INFECT$0

P51 · FY2002 · RR

ANIMAL MODEL DEVELOPMENT FOR MICROSPORIDIOSIS:OPPORTUNISTIC INFECTIONS$0

P51 · FY2002 · RR

EPIDEMIOLOGY &EPIZOOLOGY OF MICROSPORIDIOSIS: OPPORTUNISTIC INFECTION$0

P51 · FY2002 · RR

IN VITRO SCREEN OF COMPOUNDS FOR ANTIMICROSPORIDIAL ACTIVI:OPPORTUNISTIC INFECT$0

P51 · FY2001 · RR

ANIMAL MODEL DEVELOPMENT FOR MICROSPORIDIOSIS:OPPORTUNISTIC INFECTIONS$0

P51 · FY2001 · RR

EPIDEMIOLOGY &EPIZOOLOGY OF MICROSPORIDIOSIS: OPPORTUNISTIC INFECTION$0

P51 · FY2001 · RR

PRECLINICAL EVAL. OF THERAPIES FOR MICROSPORIDIAL INFECT$397,907

N01 · FY2000 · AI

ANTIMICROSPORIDIAL DRUG DISCOVERY STUDIES$54,327

P51 · FY2000 · RR

RISK FACTORS OF INTESTINAL MICROSPORIDIOSIS IN PERSONS INFECTED W/ HIV$54,327

P51 · FY2000 · RR

PRECLINICAL EVAL. OF THERAPIES FOR MICROSPORIDIAL INFECT$0

N01 · FY2000 · AI